Philippines Pharma Report
This report offers companies, investors, policymakers, and stakeholders crucial insight into the Philippines; one of the most promising pharmaceutical markets in the Asia-Pacific region with a population of over 100…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the Philippines; one of the most promising pharmaceutical markets in the Asia-Pacific region with a population of over 100…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Luxembourg; a country that is rapidly breaking away from its reputation as simply a tiny European tax haven and…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Slovakia; a country with both political and economic stability; a Eurozone member that stands out in its region for…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country located at the heart of Europe, home to some of the world’s most important international health…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the Czech Republic; a country transforming itself from merely a producer of cheap generics to the regional headquarters of…
This report offers companies, investors, policymakers, and stakeholders crucial insight into France; a country at the forefront of innovation, creativity and new trends in the pharmaceutical and healthcare industries. With some…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Hungary; a country with more than 100 years of history in pharmaceuticals and a leading regional role in the…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the birthplace of the modern pharmaceutical industry; a country that has transitioned out of economic recession and is now…
The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the largest pharmaceutical manufacturing base and the second largest pharmaceuticals market by value in the Middle East. Despite recent…
This report is an authoritative assessment of the South African healthcare and pharma markets. It features an exclusive in-depth interview with Dr. Aaron Motsoaledi, South African Minister of Health, as…
The report offers companies, investors, policymakers, and stakeholders crucial insight into a country at the global forefront of healthcare, pharmaceutical and biotechnological innovation. It features an exclusive in-depth interview with…
See our Cookie Privacy Policy Here